Category Archives: CEO

Robert Ivy: Lifetime Achievement Award Recipient

Last April 11, 2018, in Washington, D.C, Robert Ivy was awarded the Noel Polk Lifetime Achievement Award. This honorary title was given by the Mississippi Institute of Arts and Letters (MIAL). Robert Ivy is currently the EVP of American Institute of Architects and Chief Executive Officer of FAIA.

This is the first instance that an architect has received the aforementioned prestigious award. The Noel Polk Lifetime Achievement Award is given to Mississippi-based artists and art patrons whose works signified a lifetime of creativity, performance and supporting the art industry of the state. Along with Robert Ivy are other notable public figures such as Morgan Freeman who was awarded in 2007, Eudora Welty who was recognized for her writings in 2001, Shelby Foote in 2004, as well as late artists Walter Anderson and Leontyne Prince.

Follow Robert Ivy on Twitter

According to MIAL President Nancy LaForge, she believes that Robert Ivy has made architecture more accessible to residents in Mississippi. She appreciates Mr. Ivy’s dedication and passion for the field. Robert Ivy is presently a writer, commentator, and author in international architecture, and Nancy LaForge believes that it is high time that he would be receiving his much-deserved award.

Mr. Robert Ivy, on the other hand, was honored to be part of the Noel Polk honorees. AIA President Carl Elefante also expressed his insights about Mr. Robert Ivy. Mr. Elefante believes that Mr. Ivy’s work for the AIA as CEO since 2011 has brought him to be a worthy ambassador for the architecture industry and a recipient of the said award. He mentioned that the Noel Polk Lifetime Achievement Award is a crowning achievement both in Mr. Ivy’s personal and professional life. What makes it more special is that this award is given to him as a native of Mississippi, which is truly a unique honor.

About Robert Ivy
Mr. Robert Ivy is a known figure in the architecture industry. He was previously hailed as McGraw Hill’s Editor-In-Chief. Through his expertise, he also led McGraw Hill’s construction and design in several international partnerships.

During his time at the AIA, Mr. Ivy has grown the influence of the company, which recently achieved its highest membership level from its 160 years of existence. Many of America’s architects are working as professionals globally, and they are being helped by either of the seven headquarters of AIA, which included newly established ones in China and Canada.

Mr. Ivy received his Bachelor of Arts in English at the University of the South, Sewane. He proceeded to attend Tulane University where he received his Master of Architecture. He also served in the US Navy.

Learn more about Robert Ivy: http://www.architectmagazine.com/awards/robert-ivy-receives-noel-polk-lifetime-achievement-award_o

Sahm Adrangi and Kerrisdale Capital on the Proteostasis Therapeutics’ drug

Sahm Adrangi and Kerrisdale Capital on the Proteostasis Therapeutics’ drug

Be introduced to 33-year-old Sahm Adrangi, the founder, and CIO of Kerrisdale Capital Management LLC which is a New York-based company. Kerrisdale Capital is an investment manager that is committed to long-term investments and shares its investment views with the more extensive investment community. He is a generalist who’s investments are value driven. Also, he has worked for Longacre Fund Management LLC, Chain Capital Partners, and Deutsche Bank’s leveraged finance investment banking. He attended the Yale University and received a bachelor of arts in economics.

Sahm Adrangi’s company, Kerrisdale Capital, issued a negative report on Proteostasis Therapeutics and announced a conference-call. Proteostasis Therapeutics is a clinical biopharmaceutical firm and their top drug, PTI-428, focuses on curing the genetic disorder cystic fibrosis. The firm claimed that the drug in some way increased the levels of the messenger RNA and protein consistent with the CFTR gene which malfunctions in people suffering from the disease thus resulting in fatal symptoms. Clinical data show that this drug is ineffectual.

The supposed success of the drug in its proof-of-concept trials emanates from the peculiar underperformance of the 4-person placebo group. Also, people taking the medication hardly improved. Sahm Adrangi and his company believe that the deception of the drug’s performance will fade away. Also, the drug wasn’t able to deliver convincing effectiveness results in a previous trial. Proteostasis had also planned to study on many matters, for example, the patient-reported health satisfaction, it is a mystery how the studies have never been discussed.

Sahm Adrangi’s company believes that Proteostasis has a tendency of doing away with disagreeable and unclear findings. A semi-independent team of researchers carried out an in vitro study on PTI-428, a study which produced alarmingly weak results. Proteostasis did not acknowledge this results. The drug does not work as projected and does to a limited degree anything of value in the world.

http://nymag.com/news/business/boom-brands/sam-adrangi-kerrisdale-capital-2013-10/

, , , , , , , ,
[Top]

Eric Lefkofsky: Building an Impressive Technology

Eric Lefkofsky is one of the founders of Tempus, and he is currently serving as the company’s chief executive officer. He has invested in a lot of companies before, but he has focused most of his career in the development of Tempus. He developed the company because he wanted to find the best solution on how to address the growing problem with cancer. Through his knowledge about the disease, he is trying to figure out how technology can assist the scientists around the world and create a method on how to treat the patients diagnosed with the disease. After continuous research and exploration, Eric Lefkofsky managed to develop a system that would collect the medical data of patients who are diagnosed with the disease. His primary objective is to help these people who are experiencing hardships battling the disease, and he wishes that his creation would help them shortly.

Scientists working at Tempus are trying to redefine the genomic data of a patient who are diagnosed with the disease. They would study it thoroughly until they manage to create a system of treatment that can be applied to other patients. Tempus is using an advanced algorithm that would combine all treatment methods applied by different doctors around the world. By collecting a huge amount of data from the patients, the system can create new information about how these symptoms react with each other and what things can be used to stop them. Doctors around the world have been praising the system because of the accurate information that it provides, and at the same time, it makes their work easier and more manageable.

Through the years of operation, Tempus managed to create a gigantic system that would be able to collect, analyze, and sample data to help in the advancement of global healthcare. Eric Lefkofsky wanted to thank the people who have helped him develop the system, and he assured the public that there would be more updates to the technology that he developed. So far, Tempus is offering a wide range of products and services to their clients, and it is used by a lot of doctors around the world to help them with their jobs.

[Top]

Doe Deere – article recap

Doe Deere is the creator of Lime Crime, one of the most unconventional makeup brands out there today and much beloved by Generation Z. The company is best known for their interesting line of lip products with names like “Plushies” or “Unicorn Lipstick” that unabashedly create brilliant bold and otherworldly looks that you can’t find anywhere else. As a brand, Lime Crime respects vegan culture and animal rights; all of their manufactured products are certified vegan and cruelty-free by PETA and Leaping Bunny. Recently, Doe Deere shared her success story after venturing into the cosmetics industry and how her brand started out.

 

Doe Deere was born in Russia and moved to the United States around the age of 17. She attended the Fashion Institute of Technology in New York, N.Y., where she majored in fashion design and illustration but decided to leave the school early to pursue her own clothing line. Deere’s new clothing line, Lime Crime took off in 2004; she would sell them mostly through her eBay storefront and made consistent sales after a year. All of her clothing were designed by herself and she would model them off on her social media pages. Doe Deere had a hard time finding the right makeup palette to compliment her clothing designs, so she experimented with mixing her own unique hues that were vibrant and bold.

 

By 2008, Doe Deere launched her own makeup line and her initial collection consisted of eye shadows, blush, primers, glitter and application brushes. She advertised her new products in makeup tutorial videos she posted on her blog. Through savvy advertising and word-of-mouth, her blog was quickly becoming popular and she developed a strong following. There were Lime Crime makeup giveaways and fun contests where her fans could win whimsical jewelry. Deere stresses the importance of always listening to her fans on social media and to always follow through with an appropriate response, whether it’s for feedback or criticism. By following that mindset, it has allowed her to evolve as a brand and grow. Soon, Lime Crime’s own Instagram has grown to reach 3.3 million followers and counting.

 

The inspiration for Lime Crime’s makeup line comes from elements of fairy tales, fantasies, Japanese anime, subcultures and mythical creatures. The brand’s own mascot is a unicorn and Doe Deere herself was dubbed the “Unicorn Queen” by her fans. Lime Crime’s array of beauty products include lipsticks, eye shadows, facial highlighters, hair dyes, press-on nails and many others. The brand’s newest product line called ‘Velvetines’ comes in both matte and metallic liquid lip finishes and it was quickly well-received by many individuals. Lime Crime is based in Los Angeles, California, its products are available to ship worldwide and can also be seen in many retail stores located across the United States and internationally. Learn more:  http://www.bizjournals.com/losangeles/potmsearch/detail/submission/6417482/Doe_Deere

[Top]